BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25531014)

  • 1. Understanding of xerostomia and strategies for the development of artificial saliva.
    Kho HS
    Chin J Dent Res; 2014; 17(2):75-83. PubMed ID: 25531014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Saliva substitutes].
    Bottenberg P; Kochanska B
    Rev Belge Med Dent (1984); 2006; 61(3):180-7. PubMed ID: 17408139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia.
    Łysik D; Niemirowicz-Laskowska K; Bucki R; Tokajuk G; Mystkowska J
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xerostomia: the "invisible" oral health condition.
    Friedman PK; Isfeld D
    J Mass Dent Soc; 2008; 57(3):42-4. PubMed ID: 19146117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Saliva and saliva substitutes].
    van der Reijden WA; Veerman EC; van Nieuw Amerongen A
    Ned Tijdschr Tandheelkd; 1993 Aug; 100(8):351-4. PubMed ID: 11913350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the rheological and sensory properties of a novel natural salivary substitute.
    Bugarin-Castillo Y; Bou-Fadel P; Mohamed-Ismail S; Huang N; Saint-Eve A; Mathieu V; Ramaioli M
    Eur J Pharm Sci; 2024 Aug; 199():106802. PubMed ID: 38763449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive investigation of saliva replacement liquids for the treatment of xerostomia.
    Spirk C; Hartl S; Pritz E; Gugatschka M; Kolb-Lenz D; Leitinger G; Roblegg E
    Int J Pharm; 2019 Nov; 571():118759. PubMed ID: 31622744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond dissolution: Xerostomia rinses affect composition and structure of biomimetic dental mineral in vitro.
    Moynahan MM; Wong SL; Deymier AC
    PLoS One; 2021; 16(4):e0250822. PubMed ID: 33901259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An electro-stimulating oral splint for dry mouth treatment].
    Fedele S; Wolff A; Strietzel FP; Granizo López RM; Porter S; Konttinen YT
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):30-7, 73. PubMed ID: 19263865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xerostomia and you.
    Hay KD; Gear KJ
    N Z Dent J; 2002 Jun; 98(432):46-51. PubMed ID: 12125329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer.
    Davies AN
    Palliat Med; 2000 May; 14(3):197-203. PubMed ID: 10858827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Saliva Rheological Properties and Mucin Glycosylation in Dry Mouth.
    Chaudhury NM; Shirlaw P; Pramanik R; Carpenter GH; Proctor GB
    J Dent Res; 2015 Dec; 94(12):1660-7. PubMed ID: 26446936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a combined polymer system for use in relieving the symptoms of xerostomia.
    Corcoran RA; Stovell AG; Urquhart D; Chui T; Richardson M
    J Clin Dent; 2006; 17(2):34-8. PubMed ID: 16898429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of gel-based artificial saliva on Candida colonization and saliva properties in xerostomic post-radiotherapy head and neck cancer patients: a randomized controlled trial.
    Lam-Ubol A; Matangkasombut O; Trachootham D; Tarapan S; Sattabanasuk V; Talungchit S; Paemuang W; Phonyiam T; Chokchaitam O; Mungkung OO
    Clin Oral Investig; 2021 Apr; 25(4):1815-1827. PubMed ID: 32779011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removable prosthodontic therapy and xerostomia. Treatment considerations.
    Massad JJ; Cagna DR
    Dent Today; 2002 Jun; 21(6):80-2, 84, 86-7. PubMed ID: 12073484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xerostomia: etiology, recognition and treatment.
    Guggenheimer J; Moore PA
    J Am Dent Assoc; 2003 Jan; 134(1):61-9; quiz 118-9. PubMed ID: 12555958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of xerostomia. A review.
    Guijarro Guijarro B; López Sánchez AF; Hernández Vallejo G
    Med Oral; 2001; 6(1):7-18. PubMed ID: 11488135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xerostomia in geriatric patients: a burgeoning global concern.
    Anil S; Vellappally S; Hashem M; Preethanath RS; Patil S; Samaranayake LP
    J Investig Clin Dent; 2016 Feb; 7(1):5-12. PubMed ID: 25175324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.